Amended and Restated License AgreementLicense Agreement • April 21st, 2023 • Genenta Science S.p.A. • Biological products, (no disgnostic substances)
The Amendment and Restated License Agreement (the “ARLA”) attached herewith under the Enclosure is executed on March 23, 2023 (the “ARLA Execution Date”) by and between Ospedale San Raffaele S.r.l., an Italian company having registered office at via Olgettina No. 60, 20132, Milan, Italy, Fiscal Code 07636600962, duly represented for the purposes hereof by its Managing Director, Ing. Marco Centenari (“OSR”), on the one side, and Genenta Science S.p.a., an Italian company having registered office at via Olgettina No. 60, 20132, Milan, Italy, Fiscal Code 08738490963, duly represented for the purposes hereof by its Chief Executive Officer, Mr. Pierluigi Paracchi (“Genenta”), on the other side (OSR and Genenta shall be, collectively but not jointly, defined as the “Parties” and, severally, a “Party”).
